As we all suspected ...http://www.google.com/hostednews/afp/article/ALeqM5hlzUG9Pu07OorqrPqees1-eprTzw
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%